Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News RenovoRx Inc RNXT

Healthcare Biotechnology
RenovoRx, Inc. is a clinical-stage biopharmaceutical company. The Company is developing targeted combination therapies for high unmet medical needs with a goal of improving therapeutic outcomes for cancer patients undergoing treatment. Its Trans-Arterial Micro-Perfusion (TAMP) therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:RNXT)

RenovoRx Regains Compliance with Nasdaq Stockholders' Equity Requirement

Business Wire 1 day ago

RenovoRx Highlights Recent Presentation of Clinical Data Abstract at the 2024 Society of Interventional Radiology Annual Scientific Meeting

Business Wire 3 days ago

RenovoRx Closes $11.1 Million Private Placement, Providing Cash Runway into 2026

Business Wire 4 days ago

RenovoRx Announces $11.1 Million at Market Private Placement

Business Wire 11 days ago

RenovoRx to Present at the Canaccord Genuity Horizons in Oncology Virtual Conference on April 15, 2024

Business Wire April 5, 2024

RenovoRx to Present at the 36th Annual ROTH Conference on March 19, 2024

Business Wire March 12, 2024

RenovoRx Highlights Key Leadership Promotions

Business Wire March 8, 2024

RenovoRx CEO Issues Letter to Shareholders

Business Wire February 6, 2024

RenovoRx Closes $6.1 Million Private Placement

Business Wire January 29, 2024
View More News ››

Opinion & Analysis (NDAQ:RNXT)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:RNXT)

RenovoRx Engages Oklahoma University (OU) Health as First

LOS ALTOS, Calif.--(BUSINESS WIRE)--RenovoRx, Inc. (“RenovoRx” or the “Company”) (Nasdaq: RNXT), a clinical-stage biopharmaceutical...
averagepennies - December 21, 2023

RenovoRx Announces Clinical Data Abstract at the 2024 Societ

LOS ALTOS, Calif.--(BUSINESS WIRE)--RenovoRx, Inc. (Nasdaq: RNXT), a clinical-stage biopharmaceutical company developing novel...
averagepennies - December 19, 2023

RenovoRx Files New International Patent for Novel Targeted C

RenovoRx Holds a Strong Intellectual Property (IP) Portfolio with 9 Issued Patents for its Proprietary Trans-Arterial Micro-Perfusion...
averagepennies - December 13, 2023

New video out from RNXT CEO!

https://youtu.be/Y5QcOFlvHk8?si=mmZC-JFov9HQla8X
BryceCanada - November 29, 2023

New one out from RNTX!

https://youtu.be/4Q6MWrPl66g?si=ZxR7SIXt8KiCHSwf
BryceCanada - November 20, 2023

Excellent YT analysis on RNXT!

https://youtu.be/Cz4OeKoaE-4
BryceCanada - March 29, 2023
View more Bullboard ››

Vanstar Mining Resources Inc.

Vanstar Mining Resources Inc.

Vanstar Mining’s Nelligan gold project joint venture with IAMGOLD (25% VSR/75% IMG), located 60 kilometres SW of Chibougamau, ...
View More »